Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation

被引：0
作者：
Ji-Chang Wang
Guang-Yue Li
Bo Wang
Su-Xia Han
Xin Sun
Yi-Na Jiang
Yan-Wei Shen
Can Zhou
Jun Feng
Shao-Ying Lu
Jian-Lin Liu
Mao-De Wang
Pei-Jun Liu
机构：
[1] First Affiliated Hospital of Xi’an Jiaotong University,Department of Vascular Surgery
[2] First Affiliated Hospital of Xi’an Jiaotong University,Center for Translational Medicine
[3] First Affiliated Hospital of Xi’an Jiaotong University,Department of Science and Technology
[4] First Affiliated Hospital of Xi’an Jiaotong University,Department of Oncological Radiotherapy
[5] First Affiliated Hospital of Xi’an Jiaotong University,Department of Thoracic Surgery
[6] First Affiliated Hospital of Xi’an Jiaotong University,Department of Pathology
[7] First Affiliated Hospital of Xi’an Jiaotong University,Department of Medical Oncology
[8] First Affiliated Hospital of Xi’an Jiaotong University,Department of Breast Surgery
[9] First Affiliated Hospital of Xi’an Jiaotong University,Department of Neurosurgery
[10] First Affiliated Hospital of Xi’an Jiaotong University,Key Laboratory for Tumor Precision Medicine of Shaanxi Province
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
Metformin; Metastatic breast cancer; Vessel normalization; Chemosensitization; PDGF-B;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 348 条
[1]  
Kerbel RS(2008)Tumor angiogenesis N Engl J Med 358 2039-2049
[2]  
FOLKMAN J(2002)Role of angiogenesis in tumor growth and metastasis Seminars in Oncology 29 15-18
[3]  
Ebos JML(2011)Antiangiogenic therapy: impact on invasion, disease progression, and metastasis Nat Rev Clin Oncol 8 210-1121
[4]  
Kerbel RS(2011)Normalization of the vasculature for treatment of cancer and other diseases Physiol Rev 91 1071-622
[5]  
Goel S(2018)BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer J Exp Clin Cancer Res 37 209-147
[6]  
Duda DG(2014)Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia Cancer Cell 26 605-320
[7]  
Xu L(2004)Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nat Med 10 145-2676
[8]  
Munn LL(2012)Bevacizumab added to neoadjuvant chemotherapy for breast cancer N Engl J Med 366 310-14330
[9]  
Boucher Y(2007)Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer N Engl J Med 357 2666-6545
[10]  
Fukumura D(2015)Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients Proc Natl Acad Sci 112 14325-1700
12345678910